chr9-130217928-C-G
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP7
The NM_014286.4(NCS1):āc.186C>Gā(p.Thr62Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. T62T) has been classified as Likely benign.
Frequency
Consequence
NM_014286.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NCS1 | NM_014286.4 | c.186C>G | p.Thr62Thr | synonymous_variant | Exon 3 of 8 | ENST00000372398.6 | NP_055101.2 | |
NCS1 | NM_001128826.2 | c.132C>G | p.Thr44Thr | synonymous_variant | Exon 3 of 8 | NP_001122298.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NCS1 | ENST00000372398.6 | c.186C>G | p.Thr62Thr | synonymous_variant | Exon 3 of 8 | 1 | NM_014286.4 | ENSP00000361475.3 | ||
NCS1 | ENST00000630865.1 | c.132C>G | p.Thr44Thr | synonymous_variant | Exon 3 of 8 | 3 | ENSP00000486695.1 | |||
NCS1 | ENST00000493042.1 | n.*8C>G | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461892Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 727248
GnomAD4 genome Cov.: 33
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.